Auranova Lifescience Private Limited

Auranova Lifescience Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U33111DL2016PTC290066 Incorporated 22 January 2016 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2021
₹3.85 Cr
▲ 1343% YoY
Net loss · FY 2021
₹89,798
Net margin -0.2%
EBITDA · FY 2021
-₹89,798
EBITDA margin -0.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Auranova Lifescience Private Limited

Data last updated:

Auranova Lifescience Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 January 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33111DL2016PTC290066. Its GSTIN is 07AAOCA0762A1Z1 (Delhi).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Binay Kumar and Siddharth.

Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at 59 Upper Ground Flat No. A – 1 Ghoda Mohalla Aya Nagar Near Pnb Bank, New Delhi, Delhi, India – 110047.

As per the financials filed for FY 2021, the company reported a revenue of ₹3.85 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹89,798 (net margin -0.2%) and EBITDA of -₹89,798 (EBITDA margin -0.2%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 181% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Auranova Lifescience Private Limited
CIN U33111DL2016PTC290066
Registration Number 290066
Incorporation Date 22 January 2016
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    59 Upper Ground Flat No. A – 1 Ghoda Mohalla Aya Nagar Near Pnb Bank, New Delhi, Delhi, India – 110047
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Auranova Lifescience Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Auranova Lifescience Private Limited report

Financials, compliance, directors, charges, ownership and filings for Auranova Lifescience Private Limited in one report.

Financials from FY 2016 Directors & ownership Charges & compliance

Business Activity of Auranova Lifescience Private Limited

The main business activity of Auranova Lifescience is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Auranova Lifescience Private Limited FY 2022 filings available

Auranova Lifescience Private Limited reported revenue of ₹3.85 Cr (up 1343% YoY) for FY 2021.

Revenue · FY 2021
₹3.85 Cr ▲ 1343%
Net loss · FY 2021
₹89,798 margin -0.2%
EBITDA · FY 2021
-₹89,798 margin -0.2%

Compounded Annual Growth Rate (CAGR) of Auranova Lifescience Private Limited

Revenue CAGR growth
3 years · compounded
▲ 24%
5 years · compounded
▲ 181%
EBITDA CAGR growth
1 year
▲ 45%
3 years · compounded
▼ 98%
5 years · compounded
▼ 48%

Revenue has grown at a compounded annual rate (CAGR) of 181% over five years. EBITDA rose 45% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Auranova Lifescience Private Limited

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA-₹89,798••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)-₹89,798••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Auranova Lifescience Private Limited

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profitability
EBITDA Margin-0.2%••••••••••••••••
Net Profit Margin-0.2%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Auranova Lifescience are in the company report.

Premium access

Financial statements from FY 2016

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Auranova Lifescience Private Limited

Auranova Lifescience Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Elis Pharmaceuticals (India) Private Limited₹3.87 Cr (FY 2024)••••••••18.0%••••New Delhi, Delhi, India
Bendic Health Care Private Limited₹3.86 Cr (FY 2025)••••••••25.0%••••Haridwar, Uttarakhand, India
Keyuri Pharmaceuticals Private Limited₹3.86 Cr (FY 2024)••••••••43.0%••••Kalyan, Maharashtra, India
Anina Innotherapeutics Private Limited₹3.85 Cr (FY 2025)••••••••94.0%••••Thane, Maharashtra, India
Ashvitha Pharma Private Limited₹3.85 Cr (FY 2025)••••••••100.0%••••Hyderabad, Telangana, India
Auranova Lifescience Private Limited this company₹3.85 Cr (FY 2021)••••••••1343.0%••••New Delhi, Delhi, India
Olwen Lifesciences Private Limited₹3.85 Cr (FY 2024)••••••••137.0%••••Ahmedabad, Gujarat, India
Neova Biogene Private Limited₹3.84 Cr (FY 2025)••••••••-21.0%••••Mumbai, Maharashtra, India
Samai Healthcare Private Limited₹3.84 Cr (FY 2024)••••••••15.0%••••Mumbai, Maharashtra, India
Dial Pharmaceuticals Private Limited₹3.84 Cr (FY 2025)••••••••-3.0%••••Ahmedabad, Gujarat, India
Alive Lifescience Private Limited₹3.83 Cr (FY 2025)••••••••3.0%••••Ahmedabad, Gujarat, India

Peers are the five companies nearest above and the five nearest below Auranova Lifescience by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Auranova Lifescience Private Limited

Auranova Lifescience Private Limited is audited by KUMARROY BARMAN PRASANTA & ASSOCIATES for the financial year 2020.

NameStatusAppointment DateCessation Date
KUMARROY BARMAN PRASANTA & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Auranova Lifescience Private Limited

Auranova Lifescience has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
SiddharthAdditional Director19 Nov 20223 Years 10 MonthsCurrent
Binay KumarDirector19 Mar 20206 Years 6 MonthsCurrent

Ownership and Shareholding of Auranova Lifescience Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Auranova Lifescience Private Limited

Auranova Lifescience Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Auranova Lifescience Private Limited

Employment history and EPFO contributions of people linked to Auranova Lifescience.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Auranova Lifescience Private Limited

Auranova Lifescience Private Limited has 9 board changes on record since 2016: 2 appointments and 7 cessations. The latest: Ravinder ceased to be Director on 19 Nov 2022.

Ceased
Ravinder ceased to be Director.
Appointed
Siddharth was appointed as Additional Director.
AGM
Auranova Lifescience Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Auranova Lifescience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Delhi.
Ceased
Parag Mittal ceased to be Director.
Appointed
Binay Kumar was appointed as Director.
Ceased
Kumar Mukul Anand ceased to be Director.
Ceased
Mayank ceased to be Director.
Ceased
Chandan Singh Bora ceased to be Director.
Ceased
Ajeet Kumar Singh ceased to be Additional Director.
Ceased
Gulshan Setia ceased to be Director.
Incorporation
22 Jan 2016
Auranova Lifescience Private Limited was registered on 22 Jan 2016 with Roc Delhi & aged 10 years 8 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Auranova Lifescience Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Auranova Lifescience Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Auranova Lifescience Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Auranova Lifescience Private Limited

Auranova Lifescience has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AAOCA0762A1Z1DelhiActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Auranova Lifescience Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Auranova Lifescience Private Limited

Auranova Lifescience is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 January 2016 (10+ years old) and is registered under CIN U33111DL2016PTC290066.

Auranova Lifescience reported revenue of ₹3.85 Cr for FY 2021 (up 1343% YoY).

Auranova Lifescience has 2 current directors:

Auranova Lifescience reported a net loss of ₹89,798 (net margin -0.2%) and EBITDA of -₹89,798 (EBITDA margin -0.2%) for FY 2021, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Auranova Lifescience is 24% over three years and 181% over five years. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Auranova Lifescience is 07AAOCA0762A1Z1, registered in Delhi.

The CIN (Corporate Identification Number) of Auranova Lifescience is U33111DL2016PTC290066. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Auranova Lifescience was incorporated on 22 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Auranova Lifescience by revenue are Elis Pharmaceuticals (India) Private Limited, Bendic Health Care Private Limited, Keyuri Pharmaceuticals Private Limited, Anina Innotherapeutics Private Limited, Ashvitha Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).

Ravinder ceased to be Director on 19 Nov 2022. Siddharth was appointed as Additional Director on 19 Nov 2022. Parag Mittal ceased to be Director on 26 Feb 2022. Auranova Lifescience has 9 board changes on record in total.

The registered office of Auranova Lifescience is at 59 Upper Ground Flat No. A – 1 Ghoda Mohalla Aya Nagar Near Pnb Bank, New Delhi, Delhi, India – 110047.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available